Biotechnology Clinical Trials Gene Therapy Uncategorized CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial By Staff Reports 4 years ago In an early-phase clinical trial of an experimental immunotherapy, researchers achieved durable molecular remissions in
Biotechnology cancer Clinical Trials Genomes Immunotherapies Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows By Staff Reports 4 years ago A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumor cells has been shown
Biotechnology cancer Clinical Trials Immunotherapies FDA Halts Three Multiple Myeloma Studies Evaluating Merck’s KEYTRUDA® By Staff Reports 4 years ago Merck known as MSD outside the United States and Canada, today announced that the U.S.
Biotechnology cancer Immunotherapies Combo immunotherapy may herald new standard of care for kidney cancer By Staff Reports 4 years ago Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20
ASCO 2017 Ludwig researchers present new findings at the 2017 ASCO Annual Meeting By Staff Reports 4 years ago Ludwig Cancer Research unveiled the full scope of Ludwig’s participation at this year’s American Society
Biotechnology Cell Therapy Clinical Trials First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T-Cell Immunotherapy By Staff Reports 4 years ago Phase 1 pilot study utilizes T-cell antigen presenting cells to prolong the persistence of cancer-fighting
cancer Immunotherapies Nanoparticles Reprogram Immune Cells to Fight Cancer By Staff Reports 4 years ago Researchers at Fred Hutchinson Cancer Research Center have developed biodegradable nanoparticles that can be used
Biotechnology Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed By Staff Reports 4 years ago A phase one study of 11 patients with glioblastoma who received injections of an investigational
Biotechnology cancer Immunotherapies Immune Responses Against a Virus-Related Skin Cancer Suggest Ways to Improve Immunotherapy By Staff Reports 4 years ago Researchers at Seattle’s Fred Hutchinson Cancer Research Center and the University of Washington say a
cancer Immunotherapies New Study Highlights Role for Immune Cells in Cancer’s Ability to Evade Immunotherapy By Staff Reports 4 years ago One of the main reasons cancer remains difficult to treat is that cancer cells have
Biotechnology cancer Clinical Trials Immunotherapies New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response? By Staff Reports 4 years ago Roswell Park Study with pembrolizumab in untried combination is first ovarian cancer clinical trial to
cancer Cancer Discovery Immunotherapies Molecular Switch Controlling Immune Suppression May Help Turn Up Immunotherapies By Staff Reports 5 years ago Researchers at University of California San Diego School of Medicine and Moores Cancer Center have
cancer Cancer Discovery Q&A with Heat Biologics’ Founder and CEO Jeffrey Wolf on T Cell Stimulating Cancer Immunotherapies By Staff Reports 5 years ago Immuno-oncology, a field of fast advancing science that activates a patient’s own immune system against
Biotechnology cancer Immunotherapies Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research By Staff Reports 5 years ago The Cancer Research Institute (CRI), a nonprofit organization established in 1953 to advance biomedical research